Haiyan Wu - Publications, H-index & Citations

Haiyan Wu

zhejiang university

38H指数

281论文数

1.0W被引数

收录论文 71

发表时间

The Leucine-mTOR-Autophagy Axis in Granulosa Cells Mediates Circadian Disruption-Induced Anovulation Leucine-mTOR-自噬轴在颗粒细胞中调控节律紊乱诱导的无排卵

International Journal of Biological Sciences

IF10

2026-01-01

PREAI

He, Renke; Mo, Jiaying; Lin, Zhongliang; Zhu, Kejing; Wang, Yishu; Yu, Jiaen; Wu, Haiyan; Jiang, Zhaoying; Luo, Qinyu; Liu, Xueying; Yin, Lin; Yu, Chuanjin; Sheng, Jianzhong; Ding, Guolian; Huang, Hefeng

Short-term and long-term efficacy of laparoscopic D2 lymphadenectomy combined with complete mesogastrium excision for locally advanced upper gastric cancer 腹腔镜D2淋巴结清扫联合完整胃系膜切除治疗局部晚期上 gastric cancer 的短期和长期疗效

Surgery

IF2.7

2025-12-08

PREAI

Feng Liu; Yanchang Xu; Haiyan Wu; Weixiang Chen; Junpeng Li; Hongrui Zhao; Zhengnan Xu; Zhixiong Li

Integrated Transcriptomic and Metabolomic Analyses Implicate Key Genes and Metabolic Pathways in Maize Lodging Resistance 整合转录组学和代谢组学分析揭示了玉米抗倒伏的关键基因和代谢通路

Agriculture 2025, Vol. 15, Page 2416

IF3.6

2025-11-24

OAAI

Chunlei Xue; Haiyan Wu; Xuting Zhang; Fengcheng Sun; Sainan Zhang; Zhonghao Yu; Qi Dong; Yanan Liu; Hailong Zhang; Qing Ma; Liming Wang

Design, synthesis and bioevaluation of novel hydrazide derivatives as enhancers of immunotherapy and DNA-damage response in antitumor therapy 新型酰肼衍生物的设计、合成及其作为免疫疗法和抗肿瘤治疗中DNA损伤反应增强剂的评价

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-07-01

PREAI

Hu, Zhihao; Li, Shuqing; Pan, Wanyi; Wu, Haiyan; Peng, Xiaopeng

Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy 发现高活性且口服生物利用度高的组蛋白去乙酰化酶3抑制剂作为免疫调节剂和DNA损伤反应增强剂在癌症治疗中的应用

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-01-28

PREAI

Li, Shuqing; Hu, Zhihao; Pan, Wanyi; Wu, Haiyan; Peng, Weijie; Wu, Yi; Jiang, Feng; Peng, Xiaopeng

Functional analysis of (E)-β-farnesene synthases involved in accumulation of (E)-β-farnesene in German chamomile ( Matricaria chamomilla L.)

PLANT SCIENCE

IF4.1

2025-01-01

PREAI

Tai, Yuling; Wu, Haiyan; Yang, Lu; Yuan, Yi; Chen, Youhui; Wang, Honggang; Jin, Yifan; Yu, Luyao; Li, Shuangshuang; Shi, Feng

Electrocardiographic findings for predicting the left anterior descending artery chronic total occlusion in patients with inferior ST-segment elevation myocardial infarction

SCIENTIFIC REPORTS

IF3.9

2024-11-24

OAAI

Zheng, Xiaobin; Zhang, Zhaofu; Yao, Bingqi; Wu, Haiyan

Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization

BMC CANCER

IF3.4

2024-08-08

OAAI

Lin, Wei; Gu, Chenghao; Chen, Zheyin; Xue, Shihang; Wu, Haiyan; Zeng, Liuhai

Safety of embryo cryopreservation: insights from mid-term placental transcriptional changes

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY

IF4.7

2024-07-12

OAAI

Luo, Qin-Yu; Zhang, Si-Wei; Wu, Hai-Yan; Mo, Jia-Ying; Yu, Jia-En; He, Ren-Ke; Jiang, Zhao-Ying; Zhu, Ke-Jing; Liu, Xue-Ying; Lin, Zhong-Liang; Sheng, Jian-Zhong; Zhang, Yu; Wu, Yan-Ting; Huang, He-Feng

A clinicopathologic feature-based nomogram for preoperative estimation of splenic hilar lymph node metastasis in advanced proximal gastric cancer without invasion of the greater curvature

SURGERY

IF2.7

2024-07-01

PREAI

Cai, Zhiming; Lin, Huimei; Li, Zhixiong; Zhou, Jinfeng; Chen, Weixiang; Wu, Jihuang; Zhang, Weihong; Wu, Haiyan; Guo, Zipei; Xu, Yanchang

Correlation Analysis Between Tumor Deposit and Clinicopathologic Characteristics and Prognosis of Gastric Cancer: A Multicenter Retrospective Study 胃癌肿瘤沉积与临床病理特征及预后相关性的多中心回顾性研究

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-05-30

PREAI

Li, Zhixiong; Li, Xinyu; Guan, Shen; Zhu, Guangwei; Lin, Huimei; Wu, Haiyan; Jia, Jing; Guo, Zipei; Cai, Zhiming; Zheng, Qiajun; Zhang, Haoxiang; Ruan, Fangqiu; Zheng, Xu; Yang, Chunkang; Xu, Yanchang; Ye, Jianxin

TET3 gene rs828867 G>A polymorphism reduces neuroblastoma risk in Chinese children

HELIYON

IF3.6

2024-03-01

OAAI

Zhang, Xinxin; Wang, Bo; Lin, Lei; Zhou, Chunlei; Zhu, Jinhong; Wu, Haiyan; He, Jing

Genetic variants of m7G modification genes influence neuroblastoma susceptibility m7G修饰基因的遗传变异影响神经母细胞瘤易感性

HELIYON

IF3.6

2024-01-01

OAAI

Liu, Jiabin; Deng, Changmi; Lin, Huiran; Zhang, Xinxin; Zhu, Jinhong; Zhou, Chunlei; Wu, Haiyan; He, Jing

ALKBH1 rs2267755 C>T polymorphism decreases neuroblastoma risk in Chinese children ALKBH1 rs2267755 C>T多态性降低中国儿童神经母细胞瘤的风险

JOURNAL OF CANCER

IF3.2

2024-01-01

OAAI

Zhang, Xinxin; Zhou, Chunlei; Zhao, Yemu; Deng, Changmi; Wu, Haiyan; Zhuo, Zhenjian; He, Jing

Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children 功能性TET2基因多态性增加中国儿童神经母细胞瘤的风险

IUBMB LIFE

IF3.2

2023-11-28

OAAI

Lin, Lei; Wang, Bo; Zhang, Xinxin; Deng, Changmi; Zhou, Chunlei; Zhu, Jinhong; Wu, Haiyan; He, Jing

RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children RTEL1基因多态性与中国儿童神经母细胞瘤风险

BMC CANCER

IF3.4

2023-11-24

OAAI

Zhang, Ting; Zhou, Chunlei; Guo, Jiejie; Chang, Jiamin; Wu, Haiyan; He, Jing

MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children MIR938 rs2505901t> C多态性与中国儿童神经母细胞瘤风险增加相关

BIOSCIENCE REPORTS

IF4.7

2023-11-15

OAAI

Jiang, Susu; Sun, Xiuhong; Zhang, Xinxin; Zhou, Chunlei; Wu, Haiyan; He, Jing; Yang, Wenhan

Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population

MOLECULAR THERAPY-ONCOLYTICS

IF0

2021-03-01

OAAI

Zhou, Chunlei; Wang, Yizhen; He, Lili; Zhu, Jinhong; Li, Jinghang; Tang, Yingzi; Zhou, Haixia; He, Jing; Wu, Haiyan

Phase II study of pembrolizumab (pembro) plus enzalutamide for enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC): Cohorts (C) 4 and 5 update from KEYNOTE-199

ANNALS OF ONCOLOGY

IF65.4

2020-11-01

OAAI

Vaishampayan, U. N.; Elliott, T.; Omlin, A. G.; Graff, J. N.; Hoimes, C. J.; Tagawa, S. T.; Hwang, C.; Kilari, D.; Ten Tije, A. J.; McDermott, R. S.; Gerritsen, W. R.; Wu, H.; Kim, J.; Schloss, C.; de Bono, J. S.; Antonarakis, E. S.

Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study 转移性去势抵抗性前列腺癌 (mCRPC) 患者的Pembrolizumab (pembro) 联合治疗: Ib/II期主题365研究的C组

ANNALS OF ONCOLOGY

IF65.4

2020-11-01

OAAI

Joshua, A. M.; Gurney, H.; Retz, M.; Tafreshi, A.; Fong, P. C. C.; Shore, N. D.; Romano, E.; Augustin, M.; Piulats, J. M.; Berry, W. R.; Kolinsky, M. P.; Sridhar, S. S.; Conter, H. J.; Todenhoefer, T.; Appleman, L. J.; Wu, H.; Schloss, C.; Poehlein, C. H.; de Bono, J. S.; Yu, E. Y.

研究方向